Polymorphic ventricular tachycardia (a.k.a. Torsades de Pointes) is best treated with intravenous magnesium. Patients with a prolonged QT interval have a higher risk of developing polymorphic VT.

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a rare genetic ventricular tachycardia which can result in sudden cardiac death and/or syncope in young individuals with structurally ...

Feasibility of portable stellate ganglion phototherapy device shown in retrospective analy ...

The His–Purkinje system constitutes a tiny fraction of the ventricular mass, but is specialized for rapid synchronous activation of both ventricles The pathogenic role of the Purkinje system is ...

Ventricular tachycardia arises from an abnormal electrical focus or circuit in the myocardium of the ventricle and is usually manifested as a tachyarrhythmia with a wide QRS complex on ...

- Potential first-in-class therapy with FDA IND clearance and Health Canada CTA approval designed to address underlying causes of CPVT, a life-threatening, arrhythmogenic cardiac condition - - Solid ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac ...